These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 10949101)
1. Effects of yohimbine on cerebral blood flow, symptoms, and physiological functions in humans. Cameron OG; Zubieta JK; Grunhaus L; Minoshima S Psychosom Med; 2000; 62(4):549-59. PubMed ID: 10949101 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular reactivity to mental stress is not affected by alpha2-adrenoreceptor activation or inhibition. Philippsen C; Hahn M; Schwabe L; Richter S; Drewe J; Schachinger H Psychopharmacology (Berl); 2007 Feb; 190(2):181-8. PubMed ID: 17111173 [TBL] [Abstract][Full Text] [Related]
3. Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine. Krystal JH; McDougle CJ; Woods SW; Price LH; Heninger GR; Charney DS Psychopharmacology (Berl); 1992; 108(3):313-9. PubMed ID: 1355923 [TBL] [Abstract][Full Text] [Related]
4. Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Rasmusson AM; Hauger RL; Morgan CA; Bremner JD; Charney DS; Southwick SM Biol Psychiatry; 2000 Mar; 47(6):526-39. PubMed ID: 10715359 [TBL] [Abstract][Full Text] [Related]
5. Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls. Gurguis GN; Vitton BJ; Uhde TW Psychiatry Res; 1997 Jun; 71(1):27-39. PubMed ID: 9247979 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of noradrenergic drugs on anxiety and arousal in healthy volunteers with high and low anxiety. Mizuki Y; Suetsugi M; Ushijima I; Yamada M Prog Neuropsychopharmacol Biol Psychiatry; 1996 Nov; 20(8):1353-67. PubMed ID: 9004342 [TBL] [Abstract][Full Text] [Related]
8. Effect of the alpha 2-adrenergic antagonist yohimbine on orthostatic tolerance. Farrow S; Mers A; Banta G; Steigerwalt S; Lockette W Hypertension; 1990 Jun; 15(6 Pt 2):877-80. PubMed ID: 1972139 [TBL] [Abstract][Full Text] [Related]
9. Yohimbine modulates diaspirin crosslinked hemoglobin-induced systemic hemodynamics and regional circulatory effects. Sharma AC; Gulati A Crit Care Med; 1995 May; 23(5):874-84. PubMed ID: 7736746 [TBL] [Abstract][Full Text] [Related]
10. Effects of tryptophan depletion on responses to yohimbine in healthy human subjects. Goddard AW; Charney DS; Germine M; Woods SW; Heninger GR; Krystal JH; Goodman WK; Price LH Biol Psychiatry; 1995 Jul; 38(2):74-85. PubMed ID: 7578653 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of clonidine and yohimbine on spontaneous pupillary fluctuations in healthy human volunteers. Phillips MA; Szabadi E; Bradshaw CM Psychopharmacology (Berl); 2000 May; 150(1):85-9. PubMed ID: 10867980 [TBL] [Abstract][Full Text] [Related]
12. Regional brain activation due to pharmacologically induced adrenergic interoceptive stimulation in humans. Cameron OG; Minoshima S Psychosom Med; 2002; 64(6):851-61. PubMed ID: 12461189 [TBL] [Abstract][Full Text] [Related]
14. Effect of benzodiazepine hypnotic triazolam on relationship of blood pressure and Paco2 to cerebral blood flow during human non-rapid eye movement sleep. Hiroki M; Kajimura N; Uema T; Ogawa K; Nishikawa M; Kato M; Watanabe T; Nakajima T; Takano H; Imabayashi E; Ohnishi T; Takayama Y; Matsuda H; Uchiyama M; Okawa M; Takahashi K; Fukuyama H J Neurophysiol; 2006 Apr; 95(4):2293-303. PubMed ID: 16251267 [TBL] [Abstract][Full Text] [Related]
15. Expression of altered alpha2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension. Dao TT; Kailasam MT; Parmer RJ; Le HV; Le Verge R; Kennedy BP; Ziegler G; Insel PA; Wright FA; O'Connor DT J Hypertens; 1998 Jun; 16(6):779-92. PubMed ID: 9663918 [TBL] [Abstract][Full Text] [Related]
16. Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder. Charney DS; Woods SW; Heninger GR Psychiatry Res; 1989 Feb; 27(2):173-82. PubMed ID: 2540501 [TBL] [Abstract][Full Text] [Related]
17. Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. Abrams JK; Johnson PL; Hay-Schmidt A; Mikkelsen JD; Shekhar A; Lowry CA Neuroscience; 2005; 133(4):983-97. PubMed ID: 15916857 [TBL] [Abstract][Full Text] [Related]
18. Cerebral and ocular blood flow during alpha 2-blockade: evidence for a modulated sympathetic response. Linder J Acta Physiol Scand; 1981 Dec; 113(4):511-7. PubMed ID: 6127865 [TBL] [Abstract][Full Text] [Related]
19. alpha 2-Adrenergic receptor sensitivity in depression. The plasma MHPG, behavioral, and cardiovascular responses to yohimbine. Heninger GR; Charney DS; Price LH Arch Gen Psychiatry; 1988 Aug; 45(8):718-26. PubMed ID: 2840050 [TBL] [Abstract][Full Text] [Related]
20. Plasma neuropeptide Y (NPY) increases in humans in response to the alpha 2 antagonist yohimbine. Rasmusson AM; Southwick SM; Hauger RL; Charney DS Neuropsychopharmacology; 1998 Jul; 19(1):95-8. PubMed ID: 9608581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]